Read More Pharma Industry News Novartis secures global rights to atopic dermatitis drug MOR106 In a strategic move to bolster its dermatology portfolio, Swiss pharmaceutical giant Novartis has entered into an agreement… bypharmanewsdailyJuly 21, 2018